Personalized thyroid medicine-the time is now.

Personalized thyroid medicine-the time is now. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Personalized thyroid medicine-the time is now. Abstract Text:

Terry Davies,

Personalized thyroid medicine-the time is now. Publishing Authors By Initials

T Davies,

For similar abstracts research abstracts see: abstracts research

PUBMED ID PMID:

MEDLINE DATE:

Personalized thyroid medicine-the time is now. Journal Published:

PUBLICATION TYPE: Journal Article

Journal: Thyroid : official journal of the American Thyroid

VOLUME: 17

Page Numbers: 1

Journal Abbreviation: Thyroid

ISSN: 1050-7256

DAY: 5

MONTH: Jan

YEAR: 2007

Personalized thyroid medicine-the time is now. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 9104317

Personalized thyroid medicine-the time is now. Keywords Mesh Terms:

KEYWORDS:

MESH TERMS:

Chemical & Substance for Abstract: Personalized thyroid medicine-the time is now. Information

Substance Name:

Registry Number:

Grant and Affiliation Information for Personalized thyroid medicine-the time is now.

AFFILIATION: New York, NY.

Country: United States

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: Thyroid

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Personalized thyroid medicine-the time is now Related Publications

• 'Soluble' and 'insoluble' mucins--identification of distinct populations.
• 196.
• At last we and the thyroid eye doctors see each other: birth of a new study group.
• CD8 blockade promotes antigen responsiveness to nontolerizing antigen in tolerant mice by inhibiting apoptosis of CD4+ T cells.
• CD8 blockade promotes the expansion of antigen-specific CD4+ FOXP3+ regulatory T cells in vivo.
• Cholesteatoma of the external auditory canal in an immunocompromised patient.
• Chronic inflammatory demyelinating polyneuropathy presenting with headache and papilledema.
• Controlled study of critical parent and family factors in the obesigenic environment.
• Crystal structure of CD59: implications for molecular recognition of the complement proteins C8 and C9 in the membrane-attack complex.
• Design of a genetic differential amplifier.
• Development of calpain-specific inactivators by screening of positional scanning epoxide libraries.
• Diagnosis and management of infectious pleural effusion.
• Diversity synthesis using the complimentary reactivity of rhodium(II)- and palladium(II)-catalyzed reactions.
• Effect of a Lower body Compression Garment on Recovery Following Drop-Jump Training: 1838: Board #126 May 31 9:00 AM 10:30 AM.
• Endovascular repair of a traumatic aortic transection in a pediatric patient.
• Erk MAP kinase regulates branching morphogenesis in the developing mouse kidney.
• Fame at last!
• Gel matrices for scanning gel chromatography.
• Identification of a transforming growth factor-beta1/bone morphogenetic protein 4 (TGF-beta1/BMP4) response element within the mouse tissue transglutaminase gene promoter.
• Implementation of In-vivo Dosimetry with Semiconductor Diodes at Hammersmith Hospitals NHS Trust.
• Naturally occurring antibodies for the group B streptococcal surface immunogenic protein (Sip) in pregnant women and newborn babies.
• Overexpression of the insulin-like growth factor I receptor and activation of the AKT pathway in hyperplastic endometrium.
• Personalized thyroid medicine-the time is now.
• Prevalence and clonal diversity of Campylobacter jejuni from dairy farms and urban sources.
• RCAN1-1L is overexpressed in neurons of Alzheimer's disease patients.
• Reduction in proteinuria attenuates hyperlipidemia in the nephrotic syndrome.
• Steroid and prescription medicine abuse in the health and fitness community: A regional study.
• Structural modeling of snow flea antifreeze protein.
• The common gamma chain cytokines interleukin (IL)-2 and IL-7 indirectly modulate blood fluke development via effects on CD4+ T cells.
• The regulation of tau phosphorylation by PCTAIRE 3: implications for the pathogenesis of Alzheimer's disease.